Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies

Personalized treatment vs. standard of care is much debated, especially in clinical practice. Here we investigated whether overall survival differences in metastatic colorectal cancer patients are explained by tumor mutation profiles or by treatment differences in real clinical practice. Our retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendricks, Alexander, Amallraja, Anu, Meißner, Tobias, Forster, Peter, Rosenstiel, Philip, Burmeister, Greta, Schafmayer, Clemens, Franke, Andre, Hinz, Sebastian, Forster, Michael, Williams, Casey B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072525/
https://www.ncbi.nlm.nih.gov/pubmed/32046290
http://dx.doi.org/10.3390/cancers12020393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072525/
https://www.ncbi.nlm.nih.gov/pubmed/32046290
http://dx.doi.org/10.3390/cancers12020393

Ejemplares similares